One of the most fascinating examples of personalized nutrition in action is a compound called urolithin A (UA) — a postbiotic created when certain gut bacteria convert ellagitannins and ellagic acid from foods like pomegranates, walnuts, berries, and tea into bioactive metabolites.
Emerging research suggests urolithin A may support:
- Healthy aging
- Mitochondrial health
- Muscle endurance
- Gut barrier integrity
- Inflammatory balance
- Cellular resilience
This area of research offers a hopeful perspective on personalized nutrition, but I’d like to see more research before I get too practical about it — as you’ll see below, the people who’d benefit most from a supplement are looking at an expensive product. My approach is always food first until it’s not realistic, and then filling in the gaps with strategic supplements depending on your goals. The research here is interesting and reinforces something important: our bodies are adaptable, our microbiomes are dynamic ecosystems, and food still matters deeply — even when responses vary from person to person.
Why Some People Produce Urolithin A — and Others Don’t
Not everyone can efficiently convert ellagitannins into urolithin A. Researchers have identified three major urolithin metabotypes based on gut microbial activity:
UM-A
Produces primarily urolithin A and is associated with more favorable HDL-cholesterol and apolipoprotein A-I levels.[11]
UM-B
Produces additional metabolites including urolithin B and isourolithin A. This metabotype has been associated with higher LDL-cholesterol and increased oxidative stress markers.[11]
UM-0
Non-producers who generate little to no urolithin A from food sources. These individuals may theoretically benefit most from direct supplementation.[7]
What makes this especially interesting is that metabotypes appear relatively stable over time and are largely independent of age, food source, or health status.[11] The reason appears to come down to the microbiome itself — again, the gut is involved.
Recent discoveries identified specific Enterocloster species carrying a specialized “ucd operon” responsible for the final conversion step into urolithin A.[9]
Why Food Still Matters — Even If Conversion Is Limited
This does not mean foods like pomegranate or berries are “useless” if someone is a poor urolithin producer. Whole foods still provide:
- Fiber
- Polyphenols
- Antioxidants
- Prebiotic compounds
- Microbiome diversity support
In fact, ellagitannin-rich foods may help nourish beneficial bacteria including Lactobacillus, Bifidobacterium, and Akkermansia.[10]
| Food Source | Ellagic Acid Content | Practical Serving | Prebiotic Bonus |
|---|---|---|---|
| Pomegranate juice | ~25–100 mg EA equivalents | 1 cup/day | Supports Lactobacillus & Akkermansia |
| Pomegranate arils | Higher whole-food content | ½ cup/day | Fiber + polyphenols |
| Walnuts | ~60–90 mg/100g | 1 oz/day | Omega-3 ALA + fiber |
| Raspberries | ~40–50 mg/100g | 1 cup/day | High fiber, low glycemic |
| Blackberries | ~40–60 mg/100g | 1 cup/day | Anthocyanins + fiber |
| Strawberries | ~20–30 mg/100g | 1 cup/day | Vitamin C + fiber |
| Green/black tea | 0.6–18 mg/cup | 2–3 cups/day | Catechins + L-theanine |
The Gut Barrier, Inflammation & Detox Pathways
One reason urolithin A has generated so much interest is its potential connection to gut barrier function and cellular resilience. Research suggests UA may:
- Support tight junction proteins
- Increase protective mucin production
- Modulate inflammatory signaling
- Support mitochondrial quality control (mitophagy)
- Influence AhR and Nrf2 pathways involved in antioxidant and detoxification responses[4, 5]
This connects closely to the gut–liver axis and the body’s natural detoxification systems — a significant connection.
It’s important to note that “detox” in evidence-based nutrition is not about restrictive cleanses or quick fixes. The body already has sophisticated detoxification systems involving the liver, kidneys, gut, skin, lungs, and lymphatic system. Nutrition and microbiome health help support these systems.
| Detox Pathway | Proposed UA Mechanism | Practical Relevance |
|---|---|---|
| Liver Phase I | AhR activation & CYP1A1 signaling | Supports cellular defense pathways |
| Liver Phase II | Nrf2 activation → GSTs, UGTs, antioxidant enzymes | Supports conjugation pathways |
| Liver Phase III | Efflux transporter support | Assists export of metabolites |
| Gut barrier | Tight junction + mucin support | Supports intestinal integrity |
| Stool elimination | SCFA & microbial modulation | Supports healthy elimination |
| Kidneys | Renal excretion of metabolites | Primary elimination route |
| Systemic inflammation | NF-κB & CRP modulation | Supports inflammatory balance |
While the mechanistic data are compelling, many findings remain preclinical and human outcome studies are still emerging.[4]
Dosing, Timing & Duration
Human trials have primarily studied synthetic urolithin A supplementation.[1, 2, 7]
| Parameter | Evidence |
|---|---|
| Most studied dose | 1,000 mg/day |
| Lower studied doses | 10–500 mg/day |
| Biomarker changes | ~4 weeks |
| Functional changes | ~2–4 months |
| Timing | Typically taken with food |
| Safety testing | Up to 2,000 mg single dose studied[6] |
The strongest human evidence currently supports improvements in mitochondrial biomarkers and muscle endurance rather than dramatic disease reversal.[2, 3]
Biomarkers That May Be Helpful to Track
| Biomarker | What It Reflects | Expected Change with UA | Practical Availability |
|---|---|---|---|
| hs-CRP | Systemic inflammation | Potential decrease | Standard lab |
| Acylcarnitines | Mitochondrial fat oxidation | Potential decrease | Specialty metabolomics |
| Ceramides | Cardiometabolic stress | Potential decrease | Specialty lipid panel |
| Creatine kinase (CK) | Muscle recovery | Potential decrease | Standard lab |
| Urinary urolithins | Producer status | Presence/absence | Research settings |
| Microbiome diversity | Conversion capacity | Greater diversity associated with production | Stool testing |
Practical Clinical Perspective
The current evidence around urolithin A is promising, but still early. Key limitations include:
- Small human trial sizes
- Short durations (typically ≤ 4 months)
- Mostly healthy or older adult populations
- Limited disease-specific trials
- Heavy manufacturer funding in some studies
Still, this research highlights an important concept: personalized nutrition matters. Some individuals may respond differently to foods, supplements, and lifestyle interventions because of differences in:
- Gut microbiome composition
- Barrier integrity
- Inflammation
- Detoxification capacity
- Energy metabolism
That does not mean people are “broken.” It means healthcare is becoming more individualized.
My Foundational Recommendations
For most people, foundational lifestyle habits remain the most important intervention — diverse plant intake, adequate protein, fiber-rich foods, stress regulation, sleep, movement, blood sugar balance, nervous system support, and reducing unnecessary inflammatory burden. These habits help create a resilient internal environment that supports both the microbiome and the body’s natural detoxification systems.
Eating for Your Microbes, or for Your Mitochondria?
The question for the health-conscious individual is no longer just “What am I eating?” but rather: Are you eating for your microbes, or are you eating for your mitochondria? Given the microbiome bottleneck described above, the answer likely requires a strategic combination of both.
Disclaimer: This article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider before starting supplements or making significant dietary or lifestyle changes, especially if you are pregnant, breastfeeding, taking medications, or managing a medical condition.
If you want to seek personalized care with group or one-on-one sessions, then contact me here.
If you want to check out labs and supplements, then check out my Fullscript.
I use Fullscript to ensure you receive high-quality, professional-grade supplements. As a practitioner, I receive a margin on products purchased through my dispensary, which supports the time I spend researching these recommendations for you.
Reference List
- 1. Kuerec AH, Lim XK, Khoo AL, et al. Targeting Aging With Urolithin A in Humans: A Systematic Review. Ageing Research Reviews. 2024.
- 2. Liu S, D’Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Network Open. 2022.
- 3. Whitfield J, McKay AKA, Tee N, et al. Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners. Sports Medicine. 2025.
- 4. Thakur S, Chaitanya MVNL, Singh SK, et al. Urolithin A: A Novel Postbiotic for Inflammation, Aging, and Cancer. Molecular Biology Reports. 2026.
- 5. Djedjibegovic J, Marjanovic A, Panieri E, Saso L. Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress. Oxidative Medicine and Cellular Longevity. 2020.
- 6. Heilman J, Andreux P, Tran N, et al. Safety Assessment of Urolithin A. Food and Chemical Toxicology. 2017.
- 7. Singh A, D’Amico D, Andreux PA, et al. Direct Supplementation With Urolithin A Overcomes Limitations of Dietary Exposure and Gut Microbiome Variability. European Journal of Clinical Nutrition. 2022.
- 8. Ceci C, Graziani G, Faraoni I, Cacciotti I. Strategies to Improve Ellagic Acid Bioavailability. Nanotechnology. 2020.
- 9. Pidgeon R, Mitchell S, Shamash M, et al. Diet-Derived Urolithin A Is Produced by a Dehydroxylase Encoded by Human Gut Enterocloster Species. Nature Communications. 2025.
- 10. Yin Y, Martínez R, Zhang W, Estévez M. Crosstalk Between Dietary Pomegranate and Gut Microbiota. Critical Reviews in Food Science and Nutrition. 2024.
- 11. García-Villalba R, Giménez-Bastida JA, Cortés-Martín A, et al. Urolithins: A Comprehensive Update on Their Metabolism, Bioactivity, and Associated Gut Microbiota. Molecular Nutrition & Food Research. 2022.